NM_000527.5:c.1175G>A
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PM1PS4_SupportingPP3PP4PP1
This summary comes from the ClinGen Evidence Repository: The NM_000527.5(LDLR):c.1175G>A (p.Cys392Tyr) variant is classified as Likely Pathogenic for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PM1, PM2, PP1, PP3, PP4 and PS4_Supporting as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on January 31, 2025.The supporting evidence is as follows:PM2: This variant is absent from gnomAD (gnomAD v4.1.0).PP3: REVEL = 0.966. It is above 0.75.PM1: Variant meets PM2 and is missense in exon 4 and alters Cys392, one of the cysteine residues listed.PS4_Supporting, PP4: Variant meets PM2 and is identified in 2 unrelated index cases from different labs (1 case with DLCN>=6 from Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies, France; 1 case with DLCN>=6 from Cardiovascular Genetics Laboratory, PathWest Laboratory Medicine WA, Australia), after alternative causes of high cholesterol were excluded.PP1: Variant segregates with FH phenotype in 2 informative meiosis from 1 family from Cardiovascular Genetics Laboratory, PathWest Laboratory Medicine WA, Australia: 2 affected family members have the variant. LINK:https://erepo.genome.network/evrepo/ui/classification/CA16616209/MONDO:0007750/013
Frequency
Consequence
NM_000527.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LDLR | NM_000527.5 | c.1175G>A | p.Cys392Tyr | missense_variant | Exon 8 of 18 | ENST00000558518.6 | NP_000518.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Hypercholesterolemia, familial, 1 Pathogenic:2Uncertain:2
The NM_000527.5(LDLR):c.1175G>A (p.Cys392Tyr) variant is classified as Likely Pathogenic for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PM1, PM2, PP1, PP3, PP4 and PS4_Supporting as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on January 31, 2025. The supporting evidence is as follows: PM2: This variant is absent from gnomAD (gnomAD v4.1.0). PP3: REVEL = 0.966. It is above 0.75. PM1: Variant meets PM2 and is missense in exon 4 and alters Cys392, one of the cysteine residues listed. PS4_Supporting, PP4: Variant meets PM2 and is identified in 2 unrelated index cases from different labs (1 case with DLCN>=6 from Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies, France; 1 case with DLCN>=6 from Cardiovascular Genetics Laboratory, PathWest Laboratory Medicine WA, Australia), after alternative causes of high cholesterol were excluded. PP1: Variant segregates with FH phenotype in 2 informative meiosis from 1 family from Cardiovascular Genetics Laboratory, PathWest Laboratory Medicine WA, Australia: 2 affected family members have the variant. -
- -
- -
This sequence change replaces cysteine with tyrosine at codon 392 of the LDLR protein (p.Cys392Tyr). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and tyrosine. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a LDLR-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. In summary, this variant is a rare missense change with uncertain impact on protein function. It is not expected to cause disease, but the available evidence is currently insufficient to prove that conclusively. Therefore, it has been classified as a Variant of Uncertain Significance. -
Familial hypercholesterolemia Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at